January 14, 2026 11:02 pm

Tag: Crohn’s Disease

New Hope for Severe Crohn’s: Breakthrough Drug Targets Scarring

Agomab Therapeutics has launched a groundbreaking clinical trial for ontunisertib, a drug specifically targeting fibrostenosing Crohn’s disease—the severe, scarring form that has limited treatment options. This represents the first targeted therapy designed to address the root cause of intestinal scarring rather than just managing symptoms.

The FMT Study That Didn’t Work: What It Teaches Us About Crohn’s

A recent study tested fecal microbiota transplantation (FMT) for Crohn’s disease with disappointing results—but what can we learn from this setback? While FMT didn’t improve remission rates in 8 weeks, the research offers valuable insights for future treatments and reminds us that progress in IBD research often comes through understanding what doesn’t work.

Cannabis and Crohn’s: New Study Reveals Unexpected Risks

A new study examining over 4,000 Crohn’s patients reveals that cannabis users experienced higher rates of hospitalizations, surgeries, and disease flares. While cannabis may provide symptom relief, researchers suggest it could mask underlying disease progression, raising important questions about balancing short-term comfort with long-term health outcomes.

You Missed

Total Abdominal Colectomy Shows Promise for Ulcerative Colitis: What This Means for Your Treatment Journey

Total Abdominal Colectomy Shows Promise for Ulcerative Colitis: What This Means for Your Treatment Journey

January 12, 2026
This Week in IBD: Your Weekly Roundup for January 5-11, 2026

This Week in IBD: Your Weekly Roundup for January 5-11, 2026

January 11, 2026
Breakthrough in Crohn's Treatment: New Experimental Drug Offers Hope for Remission

Breakthrough in Crohn’s Treatment: New Experimental Drug Offers Hope for Remission

January 11, 2026
Young Adults with IBD Navigate Complex Healthcare Barriers and Financial Strain

Young Adults with IBD Navigate Complex Healthcare Barriers and Financial Strain

January 11, 2026